Endocarditis: Clinical Trials

3 trials for Endocarditis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 3 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Terminated 3
Phase 11Terminated 1

Follow Endocarditis: new trials by email Literature Review of Endocarditis trials Research Report on Endocarditis

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Dalbavancin Compared to Standard of Care Antibiotic Therapy for the Completion of Treatment of Patients With Complicated Bacteremia or Infective Endocarditis
Dalbavancin, Standard of Care - Endocarditis, Bacteremia
Phase 2TerminatedAbbVie22017-05-122022-04-25
Assessment of Radiolabeled rhAnnexin V-128 in Infective Endocarditis
99mTc-Annexin V-128 SPECT - Endocarditis, Thrombosis
Phase 1 / Phase 2TerminatedInstitut National de la Santé Et de la Recherche Médicale, France112016-02-052021-08-26
Phase 2 Study of Safety, Efficacy, and Pharmacokinetics of Higher Doses of Daptomycin and Vancomycin in MRSA Bacteremia
daptomycin, vancomycin - Endocarditis, Bacterial, Infective Endocarditis
Phase 2TerminatedCubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)382008-09-172018-12-24

Narrower conditions

Bacteremia (2)  ·  Endocarditis, Bacterial (1)  ·  Gram-Positive Bacterial Infections (1)  ·  Staphylococcal Infections (1)  ·  Thrombosis (1)

Broader conditions

Cardiovascular Diseases (3)  ·  Heart Diseases (3)  ·  Bacterial Infections (2)  ·  Bacterial Infections and Mycoses (2)  ·  Infections (2)  ·  Inflammation (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Sepsis (2)  ·  Systemic Inflammatory Response Syndrome (2)  ·  Cardiovascular Infections (1)  ·  Embolism and Thrombosis (1)  ·  Vascular Diseases (1)

Interventions

Daptomycin (1)  ·  Injections (1)  ·  Standard of Care (1)  ·  Vancomycin (1)  ·  dalbavancin (1)

Sponsors

AbbVie (1)  ·  Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (1)  ·  Institut National de la Santé Et de la Recherche Médicale, France (1)

Countries

United States (2)  ·  France (1)

Top investigators

Dominique Le Guludec, MD, PhD (1)  ·  Peter Pertel, MD (1)  ·  Urania Rappo, MD (1)